Orbimed Advisors - FORWARD PHARMA A/S ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of FORWARD PHARMA A/S
ValueSharesWeighting
Q4 2016$11,970,000
-28.5%
798,0000.0%0.15%
-19.9%
Q3 2016$16,750,000
+15.5%
798,0000.0%0.19%
+26.5%
Q2 2016$14,500,000
+6.9%
798,0000.0%0.15%
+5.6%
Q1 2016$13,566,000
-25.7%
798,000
-16.9%
0.14%
-13.3%
Q4 2015$18,251,000
-19.4%
960,6000.0%0.16%
-27.6%
Q3 2015$22,632,000
-38.1%
960,6000.0%0.23%
-14.9%
Q2 2015$36,551,000
+34.4%
960,6000.0%0.27%
+15.5%
Q1 2015$27,204,000
+36.0%
960,6000.0%0.23%
+21.5%
Q4 2014$20,009,000960,6000.19%
Other shareholders
FORWARD PHARMA A/S shareholders Q3 2023
NameSharesValueWeighting ↓
BVF INC/IL 1,387,853$28,215,0004.38%
SENZAR ASSET MANAGEMENT, LLC 652,500$13,265,0003.27%
Baupost Group 6,364,059$129,381,0001.48%
Assured Investment Management LLC 1,511,043$26,982,0000.56%
Perceptive Advisors 194,718$3,959,0000.20%
Rhenman & Partners Asset Management AB 36,584$744,0000.11%
DRW Securities, LLC 17,000$346,0000.06%
NJ State Employees Deferred Compensation Plan 15,000$305,0000.06%
Freedom Investment Management, Inc. 20,178$410,0000.02%
Acrospire Investment Management LLC 942$19,0000.02%
View complete list of FORWARD PHARMA A/S shareholders